This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is NOT among features of nutrition and metabolism? a. The infant's brain ... (Read 43 times)

WWatsford

  • Hero Member
  • *****
  • Posts: 539
    • Biology Forums!
Which of the following is NOT among features of nutrition and metabolism?
 a. The infant's brain uses about 60 of the daily energy intake
  b. The fat in breast milk provides most of the energy to support rapid growth
  c. The infant's brain is larger relative to the size of the body and therefore uses more energy
  d. The protein content in breast milk can be high enough to occasionally induce protein overload

Question 2

In food exchange lists, to what group are olives assigned?
 a. Fat b. Meat
  c. Carbohydrate d. Meat substitute



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Kjones0604

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

d

Answer to Question 2

a





 

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

The oldest recorded age was 122. Madame Jeanne Calment was born in France in 1875 and died in 1997. She was a vegetarian and loved olive oil, port wine, and chocolate.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library